The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative Diseases

In this episode of AD/PD™ Session Spotlight, we delve into Forum Discussion 1, "Varying Regulatory Philosophies and AD Approval Priorities – USA, EU, Asia, and Other Parts of the World," a dynamic exchange exploring how regional regulatory approaches impact the development, approval, and accessibility of Alzheimer’s disease therapies.

Co-moderated by Agneta Nordberg (Sweden) and David Holtzman (USA), this discussion brings together insights from international regulatory and clinical experts: Naohiro Egawa (Japan), Tamara Shiner (Israel), Henrik Zetterberg (Sweden), and Pavel Balabanov (The Netherlands).

Key highlights include:

• The complex landscape of disease-modifying drug approvals, exemplified by the case of kinumab

• Contrasts in regulatory frameworks between the EMA, FDA, and Japan’s PMDA

• The evolving role of biomarkers in diagnosis and treatment selection

• Ongoing challenges in balancing risk, clinical utility, and access across diverse healthcare systems

This episode is a must-listen for global stakeholders in Alzheimer’s research, regulation, and clinical care, looking to navigate the nuances of regional policy and foster cross-border collaboration in advancing neurodegenerative disease treatments.

This podcast was created using AI to provide a quick and insightful summary of an AD/PD™ 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

The AD/PD™ 2025 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, took place on April 1-5, 2025, in Vienna Austria.

https://adpd.kenes.com/

Welcome to AD/PD™ Session Spotlight, an official podcast series by AD/PD™. The podcast will discuss the latest cutting-edge science and real-world clinical impact in Alzheimer’s, Parkinson’s, and related neurodegenerative diseases, presented at the AD/PD™ 2025 Conference.

This AI-generated series is built for medical professionals and researchers who want to stay current with the latest breakthroughs without missing a step. Each episode offers concise, curated summaries of key sessions from the AD/PD™ 2025 Conference in Vienna. From novel therapies and biomarker discovery to translational research and trial data, we’ll spotlight the science that’s moving the field forward.

Whether you’re joining us in person or tuning in from your lab, clinic, or office, this podcast brings the heart of the Conference directly to you.

Powered by AI. Driven by science.

AD/PD™ 2025 took place April 1–5, 2025 in Vienna, Austria.

For more information visit https://adpd.kenes.com

Explore year-round learning with AD/PD™ Education on UNLOK: https://unlok-education.com/ad-pd/